	Action		Date
AbbVie	USD 4.95B	13M	2025-12
Acadia Pharmaceuticals	USD 29.1M	2.97M	2025-09
ALKERMES	USD 191M	927K	2025-09
Amgen	USD 6.22B	121M	2025-12
Biogen	USD 2.17B	41.3M	2025-12
BioMarin Pharmaceutical	USD 1.3B	83.29M	2025-12
Bristol-Myers Squibb	USD 2.76B	21M	2025-09
Coherus Biosciences	USD 2.05M	2.46M	2025-09
Eli Lilly	USD 13.74B	1.56B	2025-12
Gilead Sciences	USD 1.78B	40M	2025-09
Heron Therapeutics	USD 54.57M	2.33M	2022-12
Ionis Pharmaceuticals	USD 10.47M	1.99M	2025-09
J&J	USD 14.19B	45M	2025-12
Merck	USD 6.44B	157M	2025-09
Nektar Therapeutics	USD 14.46M	1.78M	2024-06
Neurocrine Biosciences	USD 69M	300K	2025-12
Otsuka Holdings	JPY 350.53B	42.43B	2025-06
Pfizer	USD 11.47B	201M	2025-09
Regeneron Pharmaceuticals	USD 3.2B	53.6M	2025-12
Vertex Pharmaceuticals	USD 1.69B	60M	2025-12

ALKERMES Action - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.